CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
14,662
edits
Cancer Therapy Evaluation Program: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
|ProgramType=Program | |ProgramType=Program | ||
|OrgSponsor=National Cancer Institute | |OrgSponsor=National Cancer Institute | ||
|CreationLegislation= | |CreationLegislation=National Cancer Act of 1971 | ||
|Purpose=To facilitate the development of new cancer treatments by coordinating and funding clinical trials, managing the supply of investigational agents, and fostering collaborations between researchers, pharmaceutical companies, and academic institutions. The program aims to improve cancer treatment outcomes through innovative research and drug development. | |Purpose=To facilitate the development of new cancer treatments by coordinating and funding clinical trials, managing the supply of investigational agents, and fostering collaborations between researchers, pharmaceutical companies, and academic institutions. The program aims to improve cancer treatment outcomes through innovative research and drug development. | ||
|Website=https://ctep.cancer.gov/ | |Website=https://ctep.cancer.gov/ | ||
| Line 9: | Line 9: | ||
|InitialFunding=Part of the National Cancer Institute's budget | |InitialFunding=Part of the National Cancer Institute's budget | ||
|Duration=Ongoing | |Duration=Ongoing | ||
|Historic= | |Historic=No | ||
}} | }} | ||
'''Cancer Therapy Evaluation Program''' (CTEP) is a key component of the [[National Cancer Institute]] (NCI) dedicated to advancing cancer treatment through the coordination of clinical trials and the development of new therapeutic agents. It plays a pivotal role in bridging the gap between cancer research and clinical practice by managing drug development, trial oversight, and collaboration with industry partners. | '''Cancer Therapy Evaluation Program''' (CTEP) is a key component of the [[National Cancer Institute]] (NCI) dedicated to advancing cancer treatment through the coordination of clinical trials and the development of new therapeutic agents. It plays a pivotal role in bridging the gap between cancer research and clinical practice by managing drug development, trial oversight, and collaboration with industry partners. | ||